ELAN vs. IDXX

Last updated Jun 3, 2026

ELAN (Elanco Animal Health Incorporated) and IDXX (IDEXX Laboratories, Inc.) are both stocks. Both are in the Healthcare sector — ELAN in Drug Manufacturers - Specialty & Generic, IDXX in Diagnostics & Research. Over the past 5 years, ELAN returned -7.56%/yr vs 0.02%/yr for IDXX. At a 0.41 correlation, their price movements are largely independent.

Performance

ELAN vs. IDXX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elanco Animal Health Incorporated (ELAN) and IDEXX Laboratories, Inc. (IDXX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ELAN achieves a 4.42% return, which is significantly higher than IDXX's -18.58% return.

ELAN

• 1D: -0.17%
• 1M: 4.98%
• YTD: 4.42%
• 6M: 5.07%
• 1Y: 76.08%
• 3Y*: 36.85%
• 5Y*: -7.56%
• 10Y*: —

IDXX

• 1D: -2.82%
• 1M: -2.93%
• YTD: -18.58%
• 6M: -24.83%
• 1Y: 7.00%
• 3Y*: 5.37%
• 5Y*: 0.02%
• 10Y*: 20.12%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ELAN vs. IDXX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
ELAN Elanco Animal Health Incorporated	4.42%	86.87%	-18.72%	21.93%	-56.94%	-7.47%	4.14%	-6.60%	-12.42%
IDXX IDEXX Laboratories, Inc.	-18.58%	63.63%	-25.51%	36.06%	-38.04%	31.73%	91.43%	40.38%	-23.14%

Correlation

The correlation between ELAN and IDXX is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.42
Correlation (3Y) Calculated over the trailing 3-year period	0.44
Correlation (5Y) Calculated over the trailing 5-year period	0.48
Correlation (All Time) Calculated using the full available price history since Sep 21, 2018	0.41

Fundamentals

EPS ELAN : -$0.48 IDXX : $18.08
PS Ratio ELAN : 2.41 IDXX : 7.51
Total Revenue (TTM) ELAN : $4.89B IDXX : $4.45B
Gross Profit (TTM) ELAN : $2.42B IDXX : $2.76B
EBITDA (TTM) ELAN : $755.00M IDXX : $1.52B

Return for Risk

ELAN vs. IDXX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELAN

ELAN Risk / Return Rank: 83
ELAN Sharpe Ratio Rank: 84
ELAN Sortino Ratio Rank: 83
ELAN Omega Ratio Rank: 82
ELAN Calmar Ratio Rank: 81
ELAN Martin Ratio Rank: 86

IDXX

IDXX Risk / Return Rank: 46
IDXX Sharpe Ratio Rank: 46
IDXX Sortino Ratio Rank: 46
IDXX Omega Ratio Rank: 45
IDXX Calmar Ratio Rank: 46
IDXX Martin Ratio Rank: 46

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELAN vs. IDXX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ELAN	IDXX	Difference
Sharpe ratio Return per unit of total volatility	1.78	0.17	+1.61
Sortino ratio Return per unit of downside risk	2.58	0.70	+1.88
Omega ratio Gain probability vs. loss probability	1.33	1.09	+0.24
Calmar ratio Return relative to maximum drawdown	2.89	0.24	+2.66
Martin ratio Return relative to average drawdown	9.56	0.50	+9.07
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ELAN vs. IDXX - Sharpe Ratio Comparison

The current ELAN Sharpe Ratio is 1.78, which is higher than the IDXX Sharpe Ratio of 0.17. The chart below compares the historical Sharpe Ratios of ELAN and IDXX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ELAN	IDXX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.78	0.17	+1.61
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.17	0.00	-0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.61	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.12	0.51	-0.63

Drawdowns

ELAN vs. IDXX - Drawdown Comparison

The maximum ELAN drawdown since its inception was -78.00%, roughly equal to the maximum IDXX drawdown of -81.42%. Use the drawdown chart below to compare losses from any high point for ELAN and IDXX.

Drawdown Indicators

	ELAN	IDXX	Difference
Max Drawdown Largest peak-to-trough decline	-78.00%	-81.42%	+3.42%
Max Drawdown (1Y) Largest decline over 1 year	-26.23%	-31.04%	+4.81%
Max Drawdown (3Y) Largest decline over 3 years	-56.10%	-37.41%	-18.69%
Max Drawdown (5Y) Largest decline over 5 years	-78.00%	-54.00%	-24.00%
Max Drawdown (10Y) Largest decline over 10 years	—	-54.00%	—
Current Drawdown Current decline from peak	-35.65%	-28.16%	-7.49%
Average Drawdown Average peak-to-trough decline	-39.82%	-21.00%	-18.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.93%	14.65%	-6.72%

Volatility

ELAN vs. IDXX - Volatility Comparison

Elanco Animal Health Incorporated (ELAN) has a higher volatility of 22.38% compared to IDEXX Laboratories, Inc. (IDXX) at 8.93%. This indicates that ELAN's price experiences larger fluctuations and is considered to be riskier than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ELAN	IDXX	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.38%	8.93%	+13.45%
Volatility (6M) Calculated over the trailing 6-month period	32.54%	20.04%	+12.50%
Volatility (1Y) Calculated over the trailing 1-year period	42.96%	41.39%	+1.57%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.54%	35.27%	+10.27%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	44.19%	33.01%	+11.18%

Dividends

ELAN vs. IDXX - Dividend Comparison

Neither ELAN nor IDXX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

ELAN vs. IDXX - Profitability Comparison

The chart below illustrates the profitability comparison between Elanco Animal Health Incorporated and IDEXX Laboratories, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ELAN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Elanco Animal Health Incorporated reported a gross profit of 785.00M and revenue of 1.37B. Therefore, the gross margin over that period was 57.3%.

IDXX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a gross profit of 722.74M and revenue of 1.14B. Therefore, the gross margin over that period was 63.4%.

ELAN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Elanco Animal Health Incorporated reported an operating income of 307.00M and revenue of 1.37B, resulting in an operating margin of 22.4%.

IDXX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported an operating income of 362.59M and revenue of 1.14B, resulting in an operating margin of 31.8%.

ELAN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Elanco Animal Health Incorporated reported a net income of 57.00M and revenue of 1.37B, resulting in a net margin of 4.2%.

IDXX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a net income of 278.45M and revenue of 1.14B, resulting in a net margin of 24.4%.

Frequently Asked Questions

Can I hold both ELAN and IDXX in my portfolio?

ELAN and IDXX have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ELAN or IDXX?

ELAN has higher volatility (22.38%) compared to IDXX (8.93%). In terms of maximum drawdown, ELAN dropped -78.00% vs IDXX's -81.42%.

Which has better risk-adjusted returns?

ELAN currently has the higher Sharpe Ratio (1.78 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.